TP53 and neoplasm: Our findings, taken with the account of mutation frequency offered by others,6,13 support a model where all inactivating mutations of TP53 are essentially “equal”, and the abundance of DN mutations is more likely driven by the DNA context at those codons, rather than selection for those mutant proteins driving tumor phenotypes beyond disabling p53 activity.